IDEXX LABORATORIES INC /DE Increase (Decrease) in Accrued Liabilities
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Accrued Liabilities of -$24.50 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-10-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2015-10-28
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for the quarter ending 2015-09-30 was $3.09M, a 84.22% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for the quarter ending 2015-06-30 was -$1.36M, a 119.81% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for the quarter ending 2015-03-31 was -$26.23M.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for the quarter ending 2014-12-31 was $20.18M, a 19.76% increase year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for fiscal 2014 was $36.39M, a 120.40% increase from fiscal 2013.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for fiscal 2013 was $16.51M, a 8729.95% increase from fiscal 2012.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for fiscal 2012 was $187.00K, a 98.89% decline from fiscal 2011.
- IDEXX LABORATORIES INC /DE increase (decrease) in accrued liabilities for fiscal 2011 was $16.91M, a 44.73% decline from fiscal 2010.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $1.72M derived: sum of 2 quarters · filed 2015-10-28 | -$24.50M 10-Q · filed 2015-10-28 | -$4.33M derived: sum of 4 quarters · filed 2015-10-28 | ||||
| 2015-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$27.59M 10-Q · filed 2015-07-30 | -$7.41M derived: sum of 3 quarters · filed 2015-07-30 | $12.15M derived: sum of 4 quarters · filed 2015-10-28 | ||||
| 2015-03-31 | -$26.23M 10-Q · filed 2015-04-28 | -$6.05M derived: sum of 2 quarters · filed 2015-04-28 | $13.51M derived: sum of 3 quarters · filed 2015-10-28 | $20.40M derived: sum of 4 quarters · filed 2015-10-28 | ||||
| 2014-12-31 | $20.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $39.74M derived: sum of 2 quarters · filed 2015-10-28 | $46.62M derived: sum of 3 quarters · filed 2015-10-28 | $36.39M 10-K · filed 2015-02-17 | ||||
| 2014-09-30 | $19.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $26.45M derived: sum of 2 quarters · filed 2015-10-28 | $16.22M 10-Q · filed 2015-10-28 | $33.06M derived: sum of 4 quarters · filed 2015-10-28 | ||||
| 2014-06-30 | $6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$3.34M 10-Q · filed 2015-07-30 | $13.50M derived: sum of 3 quarters · filed 2015-07-30 | $23.00M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2014-03-31 | -$10.23M 10-Q · filed 2015-04-28 | $6.62M derived: sum of 2 quarters · filed 2015-04-28 | $16.12M derived: sum of 3 quarters · filed 2015-04-28 | $22.50M derived: sum of 4 quarters · filed 2015-04-28 | ||||
| 2013-12-31 | $16.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $26.35M derived: sum of 2 quarters · filed 2015-02-17 | $32.73M derived: sum of 3 quarters · filed 2015-02-17 | $16.51M 10-K · filed 2015-02-17 | ||||
| 2013-09-30 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $15.88M derived: sum of 2 quarters · filed 2014-10-24 | -$335.00K 10-Q · filed 2014-10-24 | -$3.27M 10-Q · filed 2013-10-22 | $3.60M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-30 | $6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | -$9.84M 10-Q · filed 2014-07-25 | -$11.69M 10-Q · filed 2013-07-23 | -$5.90M derived: sum of 3 quarters · filed 2015-02-17 | $3.17M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-03-31 | -$16.22M 10-Q · filed 2014-04-25 | -$16.92M 10-Q · filed 2013-04-23 | -$12.28M derived: sum of 2 quarters · filed 2015-02-17 | -$3.21M derived: sum of 3 quarters · filed 2015-02-17 | -$1.33M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $13.01M derived: sum of 2 quarters · filed 2015-02-17 | $14.88M derived: sum of 3 quarters · filed 2015-02-17 | $187.00K 10-K · filed 2015-02-17 | $3.01M 10-K · filed 2013-02-19 | |||
| 2012-09-30 | $9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $10.95M derived: sum of 2 quarters · filed 2013-10-22 | -$3.75M 10-Q · filed 2013-10-22 | -$3.50M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | -$12.82M 10-Q · filed 2013-07-23 | -$12.57M derived: sum of 3 quarters · filed 2014-02-18 | $9.27M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2012-03-31 | -$14.70M 10-Q · filed 2013-04-23 | -$14.45M derived: sum of 2 quarters · filed 2014-02-18 | $7.39M derived: sum of 3 quarters · filed 2014-02-18 | $18.72M derived: sum of 4 quarters · filed 2014-02-18 | ||||
| 2011-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $22.09M derived: sum of 2 quarters · filed 2014-02-18 | $33.42M derived: sum of 3 quarters · filed 2014-02-18 | $16.91M 10-K · filed 2014-02-18 | $17.56M 10-K · filed 2012-02-17 | |||
| 2011-09-30 | $21.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $33.17M derived: sum of 2 quarters · filed 2012-10-19 | $16.66M 10-Q · filed 2012-10-19 | $30.82M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-06-30 | $11.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | -$5.17M 10-Q · filed 2012-07-20 | $8.99M derived: sum of 3 quarters · filed 2013-02-19 | $18.00M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-03-31 | -$16.50M 10-Q · filed 2012-04-20 | -$12.62M 10-Q · filed 2011-04-21 | -$2.35M derived: sum of 2 quarters · filed 2013-02-19 | $6.67M derived: sum of 3 quarters · filed 2013-02-19 | $19.02M derived: sum of 4 quarters · filed 2013-02-19 | |||
| 2010-12-31 | $14.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $23.17M derived: sum of 2 quarters · filed 2013-02-19 | $35.52M derived: sum of 3 quarters · filed 2013-02-19 | $30.60M 10-K · filed 2013-02-19 | ||||
| 2010-09-30 | $9.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $21.36M derived: sum of 2 quarters · filed 2011-10-21 | $16.45M 10-Q · filed 2011-10-21 | $22.39M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-06-30 | $12.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $7.43M 10-Q · filed 2011-07-22 | $13.38M derived: sum of 3 quarters · filed 2012-02-17 | $11.56M derived: sum of 4 quarters · filed 2012-02-17 | ||||
| 2010-03-31 | -$4.92M 10-Q · filed 2011-04-21 | $1.03M derived: sum of 2 quarters · filed 2012-02-17 | -$788.00K derived: sum of 3 quarters · filed 2012-02-17 | |||||
| 2009-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $4.13M derived: sum of 2 quarters · filed 2012-02-17 | $705.00K 10-K · filed 2012-02-17 | |||||
| 2009-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | -$5.24M 10-Q · filed 2010-10-22 | ||||||
| 2009-06-30 | -$3.42M 10-Q · filed 2010-07-23 | |||||||
| 2008-12-31 | $4.26M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |